 | • レポートコード：MRC2-11QY02562 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗高血圧薬のグローバル市場について調査・分析したレポートです。種類別（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウム拮抗薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗高血圧薬の競争状況、市場シェア ・世界の抗高血圧薬市場：種類別市場規模 2015年-2020年（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウム拮抗薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬） ・世界の抗高血圧薬市場：種類別市場規模予測 2021年-2026年（利尿薬、アンジオテンシン変換酵素（ACE）阻害薬、アンジオテンシン受容体遮断薬（ARB）、カルシウム拮抗薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬） ・世界の抗高血圧薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の抗高血圧薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の抗高血圧薬市場分析：米国、カナダ ・ヨーロッパの抗高血圧薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗高血圧薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗高血圧薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗高血圧薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Pfizer、Johnson & Johnson、Sanofi、Lupin、Ranbaxy Laboratories、Merck、AstraZeneca、Daiichi Sankyo Company Limited、Takeda Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Anti-Hypertensive Drugs Market
The global Anti-Hypertensive Drugs market size is projected to reach US$ 40970 million by 2026, from US$ 40270 million in 2020, at a CAGR of 1.6%% during 2021-2026.
Global Anti-Hypertensive Drugs Scope and Market Size
Anti-Hypertensive Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Hypertensive Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Hypertensive Drugs market is segmented into
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators
Renin Inhibitors
Segment by Application, the Anti-Hypertensive Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Anti-Hypertensive Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Hypertensive Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Hypertensive Drugs Market Share Analysis
Anti-Hypertensive Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Hypertensive Drugs business, the date to enter into the Anti-Hypertensive Drugs market, Anti-Hypertensive Drugs product introduction, recent developments, etc.
The major vendors covered:
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
AstraZeneca
Daiichi Sankyo Company Limited
Takeda Pharmaceutical
1 Study Coverage
1.1 Anti-Hypertensive Drugs Product Introduction
1.2 Market Segments
1.3 Key Anti-Hypertensive Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Hypertensive Drugs Market Size Growth Rate by Type
1.4.2 Diuretics
1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.4.4 Angiotensin Receptor Blockers (ARBs)
1.4.5 Calcium Channel Blockers
1.4.6 Beta Blockers
1.4.7 Alpha Blockers
1.4.8 Vasodilators
1.4.9 Renin Inhibitors
1.5 Market by Application
1.5.1 Global Anti-Hypertensive Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Hypertensive Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anti-Hypertensive Drugs Revenue 2015-2026
2.1.2 Global Anti-Hypertensive Drugs Sales 2015-2026
2.2 Global Anti-Hypertensive Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti-Hypertensive Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-Hypertensive Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Hypertensive Drugs Competitor Landscape by Players
3.1 Anti-Hypertensive Drugs Sales by Manufacturers
3.1.1 Anti-Hypertensive Drugs Sales by Manufacturers (2015-2020)
3.1.2 Anti-Hypertensive Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-Hypertensive Drugs Revenue by Manufacturers
3.2.1 Anti-Hypertensive Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Anti-Hypertensive Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Hypertensive Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Hypertensive Drugs Revenue in 2019
3.2.5 Global Anti-Hypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-Hypertensive Drugs Price by Manufacturers
3.4 Anti-Hypertensive Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-Hypertensive Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Hypertensive Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Hypertensive Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-Hypertensive Drugs Market Size by Type (2015-2020)
4.1.1 Global Anti-Hypertensive Drugs Sales by Type (2015-2020)
4.1.2 Global Anti-Hypertensive Drugs Revenue by Type (2015-2020)
4.1.3 Anti-Hypertensive Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Hypertensive Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Hypertensive Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Hypertensive Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Hypertensive Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Hypertensive Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-Hypertensive Drugs Market Size by Application (2015-2020)
5.1.1 Global Anti-Hypertensive Drugs Sales by Application (2015-2020)
5.1.2 Global Anti-Hypertensive Drugs Revenue by Application (2015-2020)
5.1.3 Anti-Hypertensive Drugs Price by Application (2015-2020)
5.2 Anti-Hypertensive Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Hypertensive Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Hypertensive Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Hypertensive Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti-Hypertensive Drugs by Country
6.1.1 North America Anti-Hypertensive Drugs Sales by Country
6.1.2 North America Anti-Hypertensive Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-Hypertensive Drugs Market Facts & Figures by Type
6.3 North America Anti-Hypertensive Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Anti-Hypertensive Drugs by Country
7.1.1 Europe Anti-Hypertensive Drugs Sales by Country
7.1.2 Europe Anti-Hypertensive Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Hypertensive Drugs Market Facts & Figures by Type
7.3 Europe Anti-Hypertensive Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti-Hypertensive Drugs by Region
8.1.1 Asia Pacific Anti-Hypertensive Drugs Sales by Region
8.1.2 Asia Pacific Anti-Hypertensive Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-Hypertensive Drugs Market Facts & Figures by Type
8.3 Asia Pacific Anti-Hypertensive Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti-Hypertensive Drugs by Country
9.1.1 Latin America Anti-Hypertensive Drugs Sales by Country
9.1.2 Latin America Anti-Hypertensive Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-Hypertensive Drugs Market Facts & Figures by Type
9.3 Central & South America Anti-Hypertensive Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti-Hypertensive Drugs by Country
10.1.1 Middle East and Africa Anti-Hypertensive Drugs Sales by Country
10.1.2 Middle East and Africa Anti-Hypertensive Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-Hypertensive Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Anti-Hypertensive Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Anti-Hypertensive Drugs Products Offered
11.1.5 Novartis Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Anti-Hypertensive Drugs Products Offered
11.2.5 Pfizer Related Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Description and Business Overview
11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Anti-Hypertensive Drugs Products Offered
11.3.5 Johnson & Johnson Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Anti-Hypertensive Drugs Products Offered
11.4.5 Sanofi Related Developments
11.5 Lupin
11.5.1 Lupin Corporation Information
11.5.2 Lupin Description and Business Overview
11.5.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Lupin Anti-Hypertensive Drugs Products Offered
11.5.5 Lupin Related Developments
11.6 Ranbaxy Laboratories
11.6.1 Ranbaxy Laboratories Corporation Information
11.6.2 Ranbaxy Laboratories Description and Business Overview
11.6.3 Ranbaxy Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Ranbaxy Laboratories Anti-Hypertensive Drugs Products Offered
11.6.5 Ranbaxy Laboratories Related Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Description and Business Overview
11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck Anti-Hypertensive Drugs Products Offered
11.7.5 Merck Related Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Description and Business Overview
11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AstraZeneca Anti-Hypertensive Drugs Products Offered
11.8.5 AstraZeneca Related Developments
11.9 Daiichi Sankyo Company Limited
11.9.1 Daiichi Sankyo Company Limited Corporation Information
11.9.2 Daiichi Sankyo Company Limited Description and Business Overview
11.9.3 Daiichi Sankyo Company Limited Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Products Offered
11.9.5 Daiichi Sankyo Company Limited Related Developments
11.10 Takeda Pharmaceutical
11.10.1 Takeda Pharmaceutical Corporation Information
11.10.2 Takeda Pharmaceutical Description and Business Overview
11.10.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Takeda Pharmaceutical Anti-Hypertensive Drugs Products Offered
11.10.5 Takeda Pharmaceutical Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Anti-Hypertensive Drugs Products Offered
11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-Hypertensive Drugs Market Estimates and Projections by Region
12.1.1 Global Anti-Hypertensive Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-Hypertensive Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Anti-Hypertensive Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Anti-Hypertensive Drugs Sales Forecast (2021-2026)
12.2.2 North America: Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Anti-Hypertensive Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-Hypertensive Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-Hypertensive Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-Hypertensive Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-Hypertensive Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-Hypertensive Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-Hypertensive Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-Hypertensive Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-Hypertensive Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-Hypertensive Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-Hypertensive Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-Hypertensive Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-Hypertensive Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-Hypertensive Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Hypertensive Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anti-Hypertensive Drugs Market Segments
Table 2. Ranking of Global Top Anti-Hypertensive Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Hypertensive Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Diuretics
Table 5. Major Manufacturers of Angiotensin Converting Enzyme (ACE) Inhibitors
Table 6. Major Manufacturers of Angiotensin Receptor Blockers (ARBs)
Table 7. Major Manufacturers of Calcium Channel Blockers
Table 8. Major Manufacturers of Beta Blockers
Table 9. Major Manufacturers of Alpha Blockers
Table 10. Major Manufacturers of Vasodilators
Table 11. Major Manufacturers of Renin Inhibitors
Table 12. Global Anti-Hypertensive Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Anti-Hypertensive Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Anti-Hypertensive Drugs Sales by Regions 2015-2020 (K Units)
Table 15. Global Anti-Hypertensive Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global Anti-Hypertensive Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Anti-Hypertensive Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Anti-Hypertensive Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Global Anti-Hypertensive Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Anti-Hypertensive Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Hypertensive Drugs as of 2019)
Table 21. Anti-Hypertensive Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Anti-Hypertensive Drugs Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Anti-Hypertensive Drugs Price (2015-2020) (USD/Pcs)
Table 24. Anti-Hypertensive Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Anti-Hypertensive Drugs Product Type
Table 26. Date of International Manufacturers Enter into Anti-Hypertensive Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Anti-Hypertensive Drugs Sales by Type (2015-2020) (K Units)
Table 29. Global Anti-Hypertensive Drugs Sales Share by Type (2015-2020)
Table 30. Global Anti-Hypertensive Drugs Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Anti-Hypertensive Drugs Revenue Share by Type (2015-2020)
Table 32. Anti-Hypertensive Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 33. Global Anti-Hypertensive Drugs Sales by Application (2015-2020) (K Units)
Table 34. Global Anti-Hypertensive Drugs Sales Share by Application (2015-2020)
Table 35. North America Anti-Hypertensive Drugs Sales by Country (2015-2020) (K Units)
Table 36. North America Anti-Hypertensive Drugs Sales Market Share by Country (2015-2020)
Table 37. North America Anti-Hypertensive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Anti-Hypertensive Drugs Revenue Market Share by Country (2015-2020)
Table 39. North America Anti-Hypertensive Drugs Sales by Type (2015-2020) (K Units)
Table 40. North America Anti-Hypertensive Drugs Sales Market Share by Type (2015-2020)
Table 41. North America Anti-Hypertensive Drugs Sales by Application (2015-2020) (K Units)
Table 42. North America Anti-Hypertensive Drugs Sales Market Share by Application (2015-2020)
Table 43. Europe Anti-Hypertensive Drugs Sales by Country (2015-2020) (K Units)
Table 44. Europe Anti-Hypertensive Drugs Sales Market Share by Country (2015-2020)
Table 45. Europe Anti-Hypertensive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Anti-Hypertensive Drugs Revenue Market Share by Country (2015-2020)
Table 47. Europe Anti-Hypertensive Drugs Sales by Type (2015-2020) (K Units)
Table 48. Europe Anti-Hypertensive Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Anti-Hypertensive Drugs Sales by Application (2015-2020) (K Units)
Table 50. Europe Anti-Hypertensive Drugs Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Anti-Hypertensive Drugs Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Anti-Hypertensive Drugs Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Anti-Hypertensive Drugs Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Anti-Hypertensive Drugs Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Anti-Hypertensive Drugs Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Anti-Hypertensive Drugs Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Anti-Hypertensive Drugs Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Anti-Hypertensive Drugs Sales Market Share by Application (2015-2020)
Table 59. Latin America Anti-Hypertensive Drugs Sales by Country (2015-2020) (K Units)
Table 60. Latin America Anti-Hypertensive Drugs Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Anti-Hypertensive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Anti-Hypertensive Drugs Revenue Market Share by Country (2015-2020)
Table 63. Latin America Anti-Hypertensive Drugs Sales by Type (2015-2020) (K Units)
Table 64. Latin America Anti-Hypertensive Drugs Sales Market Share by Type (2015-2020)
Table 65. Latin America Anti-Hypertensive Drugs Sales by Application (2015-2020) (K Units)
Table 66. Latin America Anti-Hypertensive Drugs Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Anti-Hypertensive Drugs Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Anti-Hypertensive Drugs Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Anti-Hypertensive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Anti-Hypertensive Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Anti-Hypertensive Drugs Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Anti-Hypertensive Drugs Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Anti-Hypertensive Drugs Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Anti-Hypertensive Drugs Sales Market Share by Application (2015-2020)
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Major Businesses
Table 77. Novartis Anti-Hypertensive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Novartis Product
Table 79. Novartis Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Major Businesses
Table 82. Pfizer Anti-Hypertensive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Pfizer Product
Table 84. Pfizer Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Major Businesses
Table 87. Johnson & Johnson Anti-Hypertensive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Product
Table 89. Johnson & Johnson Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Major Businesses
Table 92. Sanofi Anti-Hypertensive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Sanofi Product
Table 94. Sanofi Recent Development
Table 95. Lupin Corporation Information
Table 96. Lupin Description and Major Businesses
Table 97. Lupin Anti-Hypertensive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Lupin Product
Table 99. Lupin Recent Development
Table 100. Ranbaxy Laboratories Corporation Information
Table 101. Ranbaxy Laboratories Description and Major Businesses
Table 102. Ranbaxy Laboratories Anti-Hypertensive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Ranbaxy Laboratories Product
Table 104. Ranbaxy Laboratories Recent Development
Table 105. Merck Corporation Information
Table 106. Merck Description and Major Businesses
Table 107. Merck Anti-Hypertensive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Merck Product
Table 109. Merck Recent Development
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Major Businesses
Table 112. AstraZeneca Anti-Hypertensive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. AstraZeneca Product
Table 114. AstraZeneca Recent Development
Table 115. Daiichi Sankyo Company Limited Corporation Information
Table 116. Daiichi Sankyo Company Limited Description and Major Businesses
Table 117. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Daiichi Sankyo Company Limited Product
Table 119. Daiichi Sankyo Company Limited Recent Development
Table 120. Takeda Pharmaceutical Corporation Information
Table 121. Takeda Pharmaceutical Description and Major Businesses
Table 122. Takeda Pharmaceutical Anti-Hypertensive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Takeda Pharmaceutical Product
Table 124. Takeda Pharmaceutical Recent Development
Table 125. Global Anti-Hypertensive Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 126. Global Anti-Hypertensive Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Anti-Hypertensive Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Anti-Hypertensive Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Anti-Hypertensive Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 130. North America: Anti-Hypertensive Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Anti-Hypertensive Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 132. Europe: Anti-Hypertensive Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Anti-Hypertensive Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 134. Asia Pacific: Anti-Hypertensive Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Anti-Hypertensive Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 136. Latin America: Anti-Hypertensive Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Anti-Hypertensive Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 138. Middle East and Africa: Anti-Hypertensive Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Anti-Hypertensive Drugs Players
Table 143. Anti-Hypertensive Drugs Customers List
Table 144. Anti-Hypertensive Drugs Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Hypertensive Drugs Product Picture
Figure 2. Global Anti-Hypertensive Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Diuretics Product Picture
Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors Product Picture
Figure 5. Angiotensin Receptor Blockers (ARBs) Product Picture
Figure 6. Calcium Channel Blockers Product Picture
Figure 7. Beta Blockers Product Picture
Figure 8. Alpha Blockers Product Picture
Figure 9. Vasodilators Product Picture
Figure 10. Renin Inhibitors Product Picture
Figure 11. Global Anti-Hypertensive Drugs Sales Market Share by Application in 2020 & 2026
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Anti-Hypertensive Drugs Report Years Considered
Figure 16. Global Anti-Hypertensive Drugs Market Size 2015-2026 (US$ Million)
Figure 17. Global Anti-Hypertensive Drugs Sales 2015-2026 (K Units)
Figure 18. Global Anti-Hypertensive Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Anti-Hypertensive Drugs Sales Market Share by Region (2015-2020)
Figure 20. Global Anti-Hypertensive Drugs Sales Market Share by Region in 2019
Figure 21. Global Anti-Hypertensive Drugs Revenue Market Share by Region (2015-2020)
Figure 22. Global Anti-Hypertensive Drugs Revenue Market Share by Region in 2019
Figure 23. Global Anti-Hypertensive Drugs Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Anti-Hypertensive Drugs Revenue in 2019
Figure 25. Anti-Hypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Anti-Hypertensive Drugs Sales Market Share by Type (2015-2020)
Figure 27. Global Anti-Hypertensive Drugs Sales Market Share by Type in 2019
Figure 28. Global Anti-Hypertensive Drugs Revenue Market Share by Type (2015-2020)
Figure 29. Global Anti-Hypertensive Drugs Revenue Market Share by Type in 2019
Figure 30. Global Anti-Hypertensive Drugs Market Share by Price Range (2015-2020)
Figure 31. Global Anti-Hypertensive Drugs Sales Market Share by Application (2015-2020)
Figure 32. Global Anti-Hypertensive Drugs Sales Market Share by Application in 2019
Figure 33. Global Anti-Hypertensive Drugs Revenue Market Share by Application (2015-2020)
Figure 34. Global Anti-Hypertensive Drugs Revenue Market Share by Application in 2019
Figure 35. North America Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 36. North America Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Anti-Hypertensive Drugs Sales Market Share by Country in 2019
Figure 38. North America Anti-Hypertensive Drugs Revenue Market Share by Country in 2019
Figure 39. U.S. Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. U.S. Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 42. Canada Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Anti-Hypertensive Drugs Market Share by Type in 2019
Figure 44. North America Anti-Hypertensive Drugs Market Share by Application in 2019
Figure 45. Europe Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Anti-Hypertensive Drugs Sales Market Share by Country in 2019
Figure 48. Europe Anti-Hypertensive Drugs Revenue Market Share by Country in 2019
Figure 49. Germany Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Anti-Hypertensive Drugs Market Share by Type in 2019
Figure 60. Europe Anti-Hypertensive Drugs Market Share by Application in 2019
Figure 61. Asia Pacific Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 62. Asia Pacific Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Anti-Hypertensive Drugs Sales Market Share by Region in 2019
Figure 64. Asia Pacific Anti-Hypertensive Drugs Revenue Market Share by Region in 2019
Figure 65. China Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. China Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Japan Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. South Korea Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. India Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Australia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Taiwan Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Indonesia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Thailand Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Malaysia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Philippines Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 86. Vietnam Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Anti-Hypertensive Drugs Market Share by Type in 2019
Figure 88. Asia Pacific Anti-Hypertensive Drugs Market Share by Application in 2019
Figure 89. Latin America Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 90. Latin America Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Anti-Hypertensive Drugs Sales Market Share by Country in 2019
Figure 92. Latin America Anti-Hypertensive Drugs Revenue Market Share by Country in 2019
Figure 93. Mexico Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Mexico Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 96. Brazil Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 98. Argentina Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Anti-Hypertensive Drugs Market Share by Type in 2019
Figure 100. Latin America Anti-Hypertensive Drugs Market Share by Application in 2019
Figure 101. Middle East and Africa Anti-Hypertensive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 102. Middle East and Africa Anti-Hypertensive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Anti-Hypertensive Drugs Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Anti-Hypertensive Drugs Revenue Market Share by Country in 2019
Figure 105. Turkey Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. Turkey Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 108. Saudi Arabia Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Anti-Hypertensive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 110. U.A.E Anti-Hypertensive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Anti-Hypertensive Drugs Market Share by Type in 2019
Figure 112. Middle East and Africa Anti-Hypertensive Drugs Market Share by Application in 2019
Figure 113. North America Anti-Hypertensive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. North America Anti-Hypertensive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Anti-Hypertensive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Europe Anti-Hypertensive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Anti-Hypertensive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Asia Pacific Anti-Hypertensive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Anti-Hypertensive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Latin America Anti-Hypertensive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Anti-Hypertensive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Middle East and Africa Anti-Hypertensive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
高血圧治療薬の世界市場（～2026年） The standard definition of high blood pressure is determined by the Joint National Committee (JNC) on Detection, Evaluation, and Diagnosis of High Blood Pressure. A person is considered to have high blood pressure after three to six elevated blood pressure measurements over several months. These def…- バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…
- 虚血性心疾患（IHD）薬の世界市場（～2026年） Ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may tr…
- 抗消化性潰瘍薬の世界市場（～2026年） Market Analysis and Insights: Global Anti Peptic Ulcer Drugs Market The global Anti Peptic Ulcer Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti Peptic Ulcer Drugs Scope and Market Size Anti Peptic Ulcer Dru…